(15) observed that patients with BM from EGFR-mutated NSCLC presented with significantly different survival prognosis with different genetic status, thus, introducing EGFR gene mutation status and establishing the lung-mol GPA scoring system. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.